" H1 revenue growth of 56% for HR management company

H1 revenue growth of 56% for HR management company

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.

" Huge opportunity with mispriced uranium assets

Meet Fission 3.0 Corp (TSXV:FUU/OTC:FISOF).

" Biotech company perfectly positioned for the New Economy

The Covid-19 pandemic continues. However, for many businesses, we have now entered a post-Covid world.

" DEEPEM survey to prioritize drill targets for exciting copper porphyry project

Mining investors have two reasons to take a keen interest in the latest news release from Peloton Minerals Corporation (

" Is this company the next GW Pharma? Phase II study now underway

With the Covid pandemic now diminishing across most jurisdictions, now is a great time for investors to be looking at other pharma subsectors.